GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ocumetics Technology Corp (TSXV:OTC) » Definitions » Return-on-Tangible-Equity

Ocumetics Technology (TSXV:OTC) Return-on-Tangible-Equity : 0.00% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ocumetics Technology Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Ocumetics Technology's annualized net income for the quarter that ended in Mar. 2024 was C$-2.52 Mil. Ocumetics Technology's average shareholder tangible equity for the quarter that ended in Mar. 2024 was C$-0.72 Mil. Therefore, Ocumetics Technology's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was N/A%.

The historical rank and industry rank for Ocumetics Technology's Return-on-Tangible-Equity or its related term are showing as below:

TSXV:OTC's Return-on-Tangible-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.23
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Ocumetics Technology Return-on-Tangible-Equity Historical Data

The historical data trend for Ocumetics Technology's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumetics Technology Return-on-Tangible-Equity Chart

Ocumetics Technology Annual Data
Trend Jul20 Jul21 Dec22 Dec23
Return-on-Tangible-Equity
- - - -

Ocumetics Technology Quarterly Data
Jul20 Jul21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,648.78 - - - -

Competitive Comparison of Ocumetics Technology's Return-on-Tangible-Equity

For the Medical Instruments & Supplies subindustry, Ocumetics Technology's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocumetics Technology's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ocumetics Technology's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Ocumetics Technology's Return-on-Tangible-Equity falls into.



Ocumetics Technology Return-on-Tangible-Equity Calculation

Ocumetics Technology's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-3.644/( (0.136+-0.567 )/ 2 )
=-3.644/-0.2155
=N/A %

Ocumetics Technology's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=-2.524/( (-0.567+-0.882)/ 2 )
=-2.524/-0.7245
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Ocumetics Technology  (TSXV:OTC) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Ocumetics Technology Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Ocumetics Technology's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Ocumetics Technology (TSXV:OTC) Business Description

Traded in Other Exchanges
Address
639 - 5th Avenue S.W., Suite 1250, Calgary, AB, CAN, T2P 0M9
Ocumetics Technology Corp is a Canadian-based research and product development company. The company is engaged in developing an accommodating intraocular lens to eliminate the need for corrective lenses, especially for people over 45 years of age.
Executives
Roger Jewett Director, Senior Officer

Ocumetics Technology (TSXV:OTC) Headlines

No Headlines